Lazard Asset Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9
| Closed | – | – | 2454 |
|
|
2024
Q4 | $0 | Hold |
9
| – | – | ﹤0.01% | 2431 |
|
|
2024
Q3 | $0 | Sell |
9
-17
| -65% | – | ﹤0.01% | 2381 |
|
|
2024
Q2 | $0 | Sell |
26
-370
| -93% | – | ﹤0.01% | 2355 |
|
|
2024
Q1 | $17K | Sell |
396
-224
| -36% | -$9.62K | ﹤0.01% | 1853 |
|
|
2023
Q4 | $23K | Buy |
620
+325
| +110% | +$12.1K | ﹤0.01% | 2042 |
|
|
2023
Q3 | $8K | Buy |
295
+11
| +4% | +$298 | ﹤0.01% | 2157 |
|
|
2023
Q2 | $17K | Sell |
284
-1,043
| -79% | -$62.4K | ﹤0.01% | 2126 |
|
|
2023
Q1 | $62K | Buy |
1,327
+914
| +221% | +$42.7K | ﹤0.01% | 1728 |
|
|
2022
Q4 | $28K | Hold |
413
| – | – | ﹤0.01% | 2056 |
|
|
2022
Q3 | $60K | Buy |
+413
| New | +$60K | ﹤0.01% | 1712 |
|